Risks of infection and mortality among patients colonized with KPC-producing Klebsiella pneumoniae: Validation of scores and proposal for management.
Clinical Infectious Diseases Dec 15, 2017
Cano A, et al. - Researchers performed this study to improve the management and indication of empirical treatment in Klebsiella pneumoniae-carbapenemase producing K. pneumoniae (KPC-Kp) colonized patients. The Giannella risk score (GRS) and INCREMENT-CPE score (ICS) were validated for indicating empirical therapy in KPC-Kp- colonized patients.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
